Axcella previews long Covid registrational trial plans in UK and US
Axcella in discussions with UK regulators for a new long Covid trial, CEO says, following Phase IIa results announced this…
By
Axcella in discussions with UK regulators for a new long Covid trial, CEO says, following Phase IIa results announced this…
ByAfter reports of possible image fabrication in studies supporting the amyloid theory for Alzheimer’s disease, we break down the slate…
ByWhile a Phase II CART-ddBCMA trial in later-line multiple myeloma has yet to start, Arcellx is already planning a Phase…
ByThe Covid-19 pandemic put human challenge trials in the spotlight, drawing attention to this design’s possibilities in infectious disease studies.
ByAs Aristea develops a palmoplantar pustulosis treatment, US and European regulators indicate different primary endpoint preferences.
ByCMO Jeff Jones shares Cullinan’s blueprint for an upcoming Phase IIb trial recruiting non-small cell lung cancer patients with EGFR…
ByClinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National…
ByThe clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
ByThank you for subscribing to Clinical Trials Arena